Ruesch Center Symposium Focuses on Early-Onset GI Cancer

John Marshall, MD, defined the focus for the scientific briefing portion of this year’s symposium: young people getting GI cancers at an alarming rate.

Read more

Learn More About the 2023 Luminary Awards

Honoring Individuals Who Have Made Transformative Strides in the Lives of Patients with Gastrointestinal Cancers

This Years Honorees

Stay Up-to-date on Ruesch Activities

Learn about new Ruesch faculty led GI cancer research, the potential impact of new grants and patient community-building initiatives.

View Report

Give to the Ruesch Center Today

One of the most meaningful gifts you can give cancer patients and their families is hope.

Make a Gift Today

Gastrointestinal (GI) Cancers are the most common and most fatal of all cancers. The Ruesch Center will re-focus national efforts on curing this deadly set of diseases.

Caring for the whole person: Learn how a multi-disciplinary approach drives patient-centered care at The Ruesch Center for the Cure of Gastrointestinal Cancers

Dr Marshall for OncLive

FDA Approval of Fruquintinib Expands Later-Line Treatment Options in mCRC

December 5th, 2023

John L. Marshall, MD, sheds light on the significance of the FDA approval of fruquintinib for patients with heavily pretreated metastatic colorectal cancer and discusses the efficacy and safety data from the FRESCO and FRESCO-2 trials that supported the decision in this population.…

Sign Up to receive all Ruesch updates directly in your Inbox

We will deliver information on upcoming educational events, current clinical trials, and cutting-edge research and trends in the GI cancer field.